Parters L P Domain VII's Net Worth
$95.7 Million
Who is Parters L P Domain VII?
Parters L P Domain VII has an estimated net worth of $95.7 Million. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., ZOGENIX, INC., TANDEM DIABETES CARE INC, Esperion Therapeutics, Inc., Clovis Oncology, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, Neothetics, Inc., Achaogen Inc, Regado Biosciences Inc, and CADENCE PHARMACEUTICALS INC.
SEC CIK
Parters L P Domain VII's CIK is 0001374150
Past Insider Trading and Trends
2009 was Parters L P Domain VII's most active year for acquiring shares with 15 total transactions. Parters L P Domain VII's most active month to acquire stocks was the month of October. 2014 was Parters L P Domain VII's most active year for disposing of shares, totalling 16 transactions. Parters L P Domain VII's most active month to dispose stocks was the month of October. 2011 saw Parters L P Domain VII paying a total of $26,143,926.10 for 7,354,771 shares, this is the most they've acquired in one year. In 2013 Parters L P Domain VII cashed out on 7,578,312 shares for a total of $16,429,220.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OBALON THERAPEUTICS INC (RSLS) Snapshot price: $0.1471
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.37% | 250K |
$4.00 | $1,000,000.00 | 813.43K |
Aug 6
| |||
Form 4
| +41.35% | 1.65M |
$1.82 | $3,000,013.38 | 5.63M |
Aug 23
| |||
Form 4
|
∞
| 3.99M |
—
|
—
| 3.99M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Neothetics, Inc. (EVFM) Snapshot price: $0.0099
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 3.09M |
$11.86 | -$2,202,438.00 | 3.09M |
Nov 25
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 3.09M |
$11.86 | -$2,202,438.00 | 3.09M |
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Regado Biosciences Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.63% | -350.00K |
—
|
—
| 2.22M |
Mar 20
| |||
Form 4
| +24.19% | 500K |
$20.00 | $10,000,000.00 | 2.57M |
Oct 21
| |||
Form 4
|
∞
| 2.07M |
$14.00 |
—
| 2.07M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Clovis Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.81% | -159.19K |
$64.58 | -$10,280,619.36 | 2.58M |
Jun 4
| |||
Form 4
| -8.36% | -250.00K |
$24.59 | -$6,148,601.43 | 2.74M |
Mar 4 - Mar 6
| |||
Form 4
| +243.65% | 2.99M |
$13.00 |
—
| 4.22M |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |